A discovery framework that predicts the behavior of adaptive immune responses by identifying microbiota necessary for antigen-specific immunotherapy, aiding in the development of Treg-based immunotherapeutics.

A class of Treg-based disease-modifying immunotherapeutics developed using the SPIRAL framework to maintain antigen-specific Tregs for protection against allergies, autoimmune diseases, and to enhance vaccine effectiveness.